Capstone holding corp.CAPS.US Overview

US StockBasic Materials

(No presentation for CAPS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

CAPS Overall Performance

CAPS AI Analysis & Strategy

CAPS Recent Performance

-1.14%

Capstone holding corp.

-1.82%

Avg of Sector

-1.14%

S&P500

CAPS PowerScanner

CAPS Key Information

CAPS Valuation Metrics

CAPS Earnings Table

CAPS Profile

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.